Scientists Create First Tool to Study Hidden Alzheimer's Target

Vanderbilt researchers developed two breakthrough compounds that let scientists study TAOK proteins for the first time, opening new paths to understanding and potentially treating Alzheimer's disease.

More than seven million Americans with Alzheimer's now have new hope for future treatments.